CytoSolv develops technology for the treatment of diabetic ulcers and other wounds.
CytoSolv Inc. engages in the development of a technology for the cure of diabetic ulcers. The company was founded in 2009 and is based in Tiverton, Rhode Island.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 20, 2012 | Grant | $150K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |